Senior Manager, Accounting and SEC Reporting

Position Overview

Bicara Therapeutics is seeking a proactive and detail-oriented Senior Manager, Accounting and SEC Reporting, to join our growing Accounting Team. This individual will report to the Senior Director, Accounting and will be responsible for preparation of all SEC reporting documents including Form 10K and 10Q. This position will also be responsible for preparing and managing G&A accruals, for performing all activities related to company’s stock compensation expenses and for working both independently and as part of a team to support Bicara's launch compliance with Sarbanes-Oxley Act requirements. This is a hands‑on position and the ability to multitask and work with others is essential.

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

Responsibilities

• Leads the preparation of Form 10-Q quarterly reports, Form 10-K annual reports, financial sections of earning press releases and other current reports as needed.
• Manages external SEC financial reporting and filing process, including internal and external comments drafting of financial statements, footnotes and MD&A, completing GAAP checklists, as well as maintaining and reviewing XBRL tagging.
• Monitors the development and applicability of emerging accounting and reporting rules being deliberated by the SEC, PCAOB, or other regulations.
• Partner with the Controller and the Senior Director of Accounting on the review and assessment of complex accounting matters and new accounting standards under U.S. GAAP, ensuring timely and accurate reporting.
• Lead accounting for stock-based compensation for compliance with ASC 718, including preparation of stock-based compensation expenses journal entries.
• Prepare and post monthly journal entries and prepare monthly account reconciliation for assigned areas including G&A accrual, cash & investment, fixed assets and leases.
• Collaborate with other G&A teams including legal, IR and others as needed to ensure that relevant information is shared timely.
• Develop and maintain accounting policies and procedures.
• Identify opportunities to streamline and automate controls and reporting processes.

Qualifications

• BS/MS in Accounting and 8 plus years of relevant experience.
• Solid understanding of US GAAP and ability to manage multiple priorities.
• Ability to research and interpret accounting guidance and draft accounting memos to support conclusions.
• Proven subject matter knowledge, demonstrated attention to detail and ability to communicate effectively with the team.
• Demonstrated strong interpersonal skills and effectiveness in working collaboratively with cross functional team members and with external partners.
• Strong team player that has a customer service approach and is solution oriented.
• Demonstrated ability and willingness to drill‑in to operational details while maintaining appropriate whole‑company perspective (zoom‑in, zoom‑out).
• Ability to work individually, within a multi‑disciplinary team, as well as with external partners and vendors.
• Excitement about the mission of Bicara.
• Prior experience at a biotech, life sciences, or other high‑growth technology company.
• Proficient knowledge of Excel, Word, PowerPoint.

Preferred Qualifications

• Active CPA license.
• Prior experience working with Workiva or similar SEC reporting platform.
• Experience working with NetSuite, Prendio and Bill.com.

Company Overview

Bicara Therapeutics is a clinical‑stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first‑in‑class bifunctional EGFR‑directed antibody combined with a TGF‑β ligand trap. Our innovative approach combines tumor‑targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF‑β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit

Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply.

Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.